Nanox Imaging Ltd. (NASDAQ: NNOX), a company focused on driving the world’s transition to preventive health care, announced that its subsidiary, Nanox AI Ltd., has entered into a distribution agreement with Technologic s.r.l., an Italian company affiliated with Tecnologie Avanzate, to commercialize its AI-powered bone health solution, HealthOST, in Italy. The agreement is intended to expand Nanox AI’s commercial presence in the Italian market, leveraging Technologic’s experience and local market knowledge.
HealthOST analyzes eligible routine CT scans to provide qualitative and quantitative assessments of the spine, helping clinicians identify patients who may benefit from further evaluation for musculoskeletal conditions such as osteoporosis. This development matters because osteoporosis is a widespread condition that often goes undiagnosed until a fracture occurs. By integrating AI into routine imaging workflows, Nanox aims to enable earlier detection and intervention, potentially reducing the burden on healthcare systems and improving patient outcomes.
The distribution agreement with Technologic is a strategic step for Nanox as it seeks to expand its global footprint. The Italian market represents a significant opportunity, given its aging population and the growing demand for innovative healthcare solutions. Technologic’s established presence and expertise in the Italian medical technology sector could accelerate the adoption of HealthOST among Italian clinicians and healthcare providers.
Nanox’s vision extends beyond traditional hospital settings. The company combines affordable imaging hardware, advanced AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care. Its ecosystem includes Nanox.ARC, a cost-effective 3D multi-source digital tomosynthesis imaging system; Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging; Nanox.CLOUD, a cloud-based platform for secure data management; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts; and Nanox Health IT, which delivers RIS, PACS, AI, dictation, and secure infrastructure solutions.
For investors, this agreement signals Nanox’s continued commitment to commercializing its AI solutions and expanding into new geographies. The latest news and updates relating to NNOX are available in the company’s newsroom at http://ibn.fm/NNOX. To view the full press release, visit https://ibn.fm/y9Zro.
The announcement was disseminated through BioMedWire, a specialized communications platform focused on the biotechnology, biomedical sciences, and life sciences sectors. BioMedWire is one of 75+ brands within the Dynamic Brand Portfolio at IBN, which delivers access to a vast network of wire solutions via InvestorWire, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement, and social media distribution via IBN to millions of social media followers. For more information, please visit https://www.BioMedWire.com. Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer.
